Functional studies in lung carcinoma cells demonstrated that pharmacological or genetic inhibition of the GluII β-subunit results in increased autophagy and p53-dependent apoptosis, supporting a regulatory role for GluII in cell survival and stress response pathways. This evidence concerns the gene GANAB and lung carcinoma.